A Psychedelic Development and Wellness Company

Trip Pharma is currently pursuing the buildout of a purpose-built facility that will provide a supply of high-quality products for use in research and prescription for clinical patients. Trip Pharma intends to conduct research in psilocybin producing mushrooms, is in the process of submitting an application for a Controlled Drugs and Substances Dealers License in Canada and is working to source a library of Psilocybin Cubensis genetics.

Trip Pharma also plans to develop a psychiatric research clinic where patients are able to access care, as well as complementary treatments, in a welcoming and stigma-free environment. If and when Trip Pharma receives its dealers license, the clinic intends to conduct research into the use of psilocybin for the treatment of depression, anxiety, post-traumatic stress, chronic pain and fatigue, sleep disorders, sexual dysfunction, and attention deficit symptomatology, and then meet with patients to gauge their interest in the use of psilocybin as a potential therapy.


Our Clinic

Led by Dr. Krista Leicht, our clinic is a multidisciplinary clinic, on the cutting edge of innovative treatments. We offer patients alternatives to conventional psychiatric and medical therapy for a wide variety of issues and conditions.

Aimed to offer both conventional and alternative therapies to help treat depression, mood disorders, anxiety, metabolic dysregulation and chronic pain among many others.